Combination pembrolizumab and reduced-dose ipilimumab: how low can you go?
CheckMate 025: Phase 3 trial of nivolumab for advanced kidney cancer
How is treatment determined in renal cell carcinoma?
Potential new treatments in renal cell carcinoma
Emerging roles of nivolumab and cabozantinib for renal cell carcinoma